In summary, the non-overlapping expression patterns and the non-redundant functions of PD-1 and PD-L1 expressed on multiple cell types within the tumor microenvironment strongly suggest a potential benefit for combined PD-1/PD-L1 targeting. This evidence concerns the gene CD274 and neoplasm.